Annual Current Liabilities
$29.89 M
+$4.78 M+19.02%
December 31, 2024
Summary
- As of March 10, 2025, NMRA annual total current liabilities is $29.89 million, with the most recent change of +$4.78 million (+19.02%) on December 31, 2024.
- During the last 3 years, NMRA annual current liabilities has risen by +$6.61 million (+28.39%).
- NMRA annual current liabilities is now at all-time high.
Performance
NMRA Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Current Liabilities
$29.89 M
-$1.86 M-5.85%
December 31, 2024
Summary
- As of March 10, 2025, NMRA quarterly total current liabilities is $29.89 million, with the most recent change of -$1.86 million (-5.85%) on December 31, 2024.
- Over the past year, NMRA quarterly current liabilities has stayed the same.
- NMRA quarterly current liabilities is now -5.85% below its all-time high of $31.74 million, reached on September 30, 2024.
Performance
NMRA Quarterly Current Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Current Liabilities Formula
Current Liabilities = Accounts Payable + Short-Term Debt + Accrued Expenses + Other Current Liabilities
NMRA Current Liabilities Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +19.0% | 0.0% |
| 3 y3 years | +28.4% | 0.0% |
| 5 y5 years | +10000.0% | 0.0% |
NMRA Current Liabilities Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +28.4% | -5.8% | +66.7% |
| 5 y | 5-year | at high | >+9999.0% | -5.8% | +218.9% |
| alltime | all time | at high | >+9999.0% | -5.8% | +218.9% |
Neumora Therapeutics Current Liabilities History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $29.89 M(+19.0%) | $29.89 M(-5.9%) |
| Sep 2024 | - | $31.74 M(+37.3%) |
| Jun 2024 | - | $23.13 M(-6.0%) |
| Mar 2024 | - | $24.61 M(-2.0%) |
| Dec 2023 | $25.11 M(+6.0%) | $25.11 M(-13.8%) |
| Sep 2023 | - | $29.12 M(+11.6%) |
| Jun 2023 | - | $26.09 M(+10.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2022 | $23.70 M(+1.8%) | $23.70 M(+3.7%) |
| Jun 2022 | - | $22.86 M(+27.5%) |
| Mar 2022 | - | $17.93 M(-23.0%) |
| Dec 2021 | $23.28 M(+148.4%) | - |
| Dec 2021 | - | $23.28 M(+11.1%) |
| Sep 2021 | - | $20.95 M(+123.6%) |
| Dec 2020 | $9.37 M(>+9900.0%) | $9.37 M |
| Dec 2019 | $21.00 K | - |
FAQ
- What is Neumora Therapeutics annual total current liabilities?
- What is the all time high annual current liabilities for Neumora Therapeutics?
- What is Neumora Therapeutics annual current liabilities year-on-year change?
- What is Neumora Therapeutics quarterly total current liabilities?
- What is the all time high quarterly current liabilities for Neumora Therapeutics?
- What is Neumora Therapeutics quarterly current liabilities year-on-year change?
What is Neumora Therapeutics annual total current liabilities?
The current annual current liabilities of NMRA is $29.89 M
What is the all time high annual current liabilities for Neumora Therapeutics?
Neumora Therapeutics all-time high annual total current liabilities is $29.89 M
What is Neumora Therapeutics annual current liabilities year-on-year change?
Over the past year, NMRA annual total current liabilities has changed by +$4.78 M (+19.02%)
What is Neumora Therapeutics quarterly total current liabilities?
The current quarterly current liabilities of NMRA is $29.89 M
What is the all time high quarterly current liabilities for Neumora Therapeutics?
Neumora Therapeutics all-time high quarterly total current liabilities is $31.74 M
What is Neumora Therapeutics quarterly current liabilities year-on-year change?
Over the past year, NMRA quarterly total current liabilities has changed by $0.00 (0.00%)